Australian Pharmaceutical Industries (ASX:API) Shares Down 1.8%

Australian Pharmaceutical Industries Ltd (ASX:API) fell 1.8% on Monday . The company traded as low as A$1.33 ($0.94) and last traded at A$1.33 ($0.94), 1,221,895 shares traded hands during mid-day trading. A decline of 24% from the average session volume of 1,600,000 shares. The stock had previously closed at A$1.36 ($0.96).

The company has a debt-to-equity ratio of 45.29, a current ratio of 1.24 and a quick ratio of 0.78. The stock has a 50 day simple moving average of A$1.38 and a two-hundred day simple moving average of A$1.37. The company has a market cap of $655.07 million and a PE ratio of 11.98.

The company also recently disclosed a final dividend, which will be paid on Thursday, December 12th. Shareholders of record on Thursday, December 12th will be paid a $0.04 dividend. This represents a yield of 2.93%. The ex-dividend date of this dividend is Wednesday, November 13th. Australian Pharmaceutical Industries’s dividend payout ratio is currently 72.07%.

Australian Pharmaceutical Industries Company Profile (ASX:API)

Australian Pharmaceutical Industries Limited engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies primarily in Australia. The company also retails health and beauty products to consumers; and manufactures and distributes pharmaceutical and toiletry goods to New Zealand, Australian, and Asian markets, as well as provides cosmetic products and procedures.

Featured Article: Understanding Market Liquidity

Receive News & Ratings for Australian Pharmaceutical Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Australian Pharmaceutical Industries and related companies with MarketBeat.com's FREE daily email newsletter.